Evogene Ltd. Form SCHEDULE 13D/A — Oct 6, 2026
L.I.A. Pure Capital, Invest Pro Shukai Hon and their principals (Kfir Silberman and Ron Yair Peled) filed Amendment No. 7 to their Schedule 13D on Evogene Ltd., disclosing a Cooperation Agreement dated October 6, 2026. The group beneficially owns 3,057,488 ordinary shares, approximately 16.94% of the 18,053,071 shares outstanding.
Key figures
- Shares Owned
- 3057488
- Standstill days
- 60
- Amendment number
- 7
- Percent of class
- 16.94%
- Shares outstanding
- 18053071
- Invest pro dispositive shares
- 500000
- Invest pro dispositive percent
- 2.77%
- Pure capital dispositive percent
- 14.17%
- Pure capital sole dispositive shares
- 2557488
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.